155 related articles for article (PubMed ID: 33660436)
1. To study the role of pre-treatment microRNA (micro ribonucleic acid) expression as a predictor of response to chemoradiation in locally advanced carcinoma cervix.
Barik S; Mitra S; Suryavanshi M; Dewan A; Kaur I; Kumar D; Mishra M; Vishwakarma G
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1348. PubMed ID: 33660436
[TBL] [Abstract][Full Text] [Related]
2. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of concurrent chemoradiotherapy with weekly carboplatin in locally-advanced carcinoma of the uterine cervix patients.
Sangkittipaiboon S
J Med Assoc Thai; 2014 Jan; 97(1):12-9. PubMed ID: 24701724
[TBL] [Abstract][Full Text] [Related]
4. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
5. A microRNA expression signature for clinical response in locally advanced cervical cancer.
Pedroza-Torres A; Fernández-Retana J; Peralta-Zaragoza O; Jacobo-Herrera N; Cantú de Leon D; Cerna-Cortés JF; Lopez-Camarillo C; Pérez-Plasencia C
Gynecol Oncol; 2016 Sep; 142(3):557-65. PubMed ID: 27423381
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Kuno I; Takayanagi D; Asami Y; Murakami N; Matsuda M; Shimada Y; Hirose S; Kato MK; Komatsu M; Hamamoto R; Okuma K; Kohno T; Itami J; Yoshida H; Shiraishi K; Kato T
Sci Rep; 2021 Sep; 11(1):19261. PubMed ID: 34584128
[TBL] [Abstract][Full Text] [Related]
11. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
[TBL] [Abstract][Full Text] [Related]
12. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
13. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
Kim JY; Byun SJ; Kim YS; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
[TBL] [Abstract][Full Text] [Related]
14. PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation.
Yoon JW; Kim S; Kim SW; Kim YT; Kang WJ; Nam EJ
Clin Nucl Med; 2016 Sep; 41(9):677-82. PubMed ID: 27276204
[TBL] [Abstract][Full Text] [Related]
15. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin.
Lachkar B; Minaguchi T; Akiyama A; Liu S; Zhang S; Xu C; Shikama A; Tasaka N; Sakurai M; Nakao S; Ochi H; Yoshikawa H; Satoh T
Medicine (Baltimore); 2018 Aug; 97(31):e11392. PubMed ID: 30075505
[TBL] [Abstract][Full Text] [Related]
17. Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
Krhili S; Muratet JP; Roche S; Pointreau Y; Yossi S; Septans AL; Denis F
Am J Clin Oncol; 2017 Jun; 40(3):250-255. PubMed ID: 27028351
[TBL] [Abstract][Full Text] [Related]
18. ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma.
Bai ZL; Wang YY; Zhe H; He JL; Hai P
Radiat Oncol; 2012 Dec; 7():221. PubMed ID: 23259415
[TBL] [Abstract][Full Text] [Related]
19. MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.
Liu YJ; Zhou HG; Chen LH; Qu DC; Wang CJ; Xia ZY; Zheng JH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):87-95. PubMed ID: 30657550
[TBL] [Abstract][Full Text] [Related]
20. Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study.
Chopra S; Deodhar K; Pai V; Pant S; Rathod N; Goda JS; Sudhalkar N; Pandey P; Waghmare S; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):161-168. PubMed ID: 30213750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]